AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group

Journal of Clinical Oncology · Published 2026-07-24 · DOI 10.1200/jco-25-02979

Authors (29)

Jessica A. Pollard, Todd A. Alonzo, Robert B. Gerbing, Matthew Kutny, Betsy Hirsch, Gordana Raca, Kasey Leger, Jennifer Wilkes, Reena Pabari, Aman Wadhwa, Zachary Graff, Samir Kahwash, Karen Chisholm, Joseph Chewning, John Horan, Richard Aplenc, Andrew Place, Sarah K. Tasian, Katherine Tarlock, Sarah Menig, Olga Militano, Bonnie Ky, Chad Hudson, Michael R. Loken, Andrew Menssen, Lisa Eidenschink Brodersen, Soheil Meshinchi, E. Anders Kolb, Todd M. Cooper

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pollard, J., Alonzo, T., Gerbing, R., et al. (2026). AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02979

Related articles

• Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab · Journal of Clinical Oncology · 2026 · Same journal
• Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program · Journal of Clinical Oncology · 2026 · Same journal
• Innovate or Be Left Behind: A Path to Prospective External Control Arms for Accelerated Oncology Drug Development · Journal of Clinical Oncology · 2026 · Same journal
• Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up · Journal of Clinical Oncology · 2026 · Same journal
• Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor · Journal of Clinical Oncology · 2026 · Same journal
• SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer · Journal of Clinical Oncology · 2026 · Same journal
• Moderate Hypofractionation for Regional Node Irradiation Is Safe and Effective · Journal of Clinical Oncology · 2026 · Same journal
• Beyond Statistical Significance: Methodological Fragility and Censoring Bias in the 5-Year Update of CheckMate 743 · Journal of Clinical Oncology · 2026 · Same journal
• Limiting Dexamethasone Exposure With Highly Emetogenic Chemotherapy Regimens: Is the Verdict In? · Journal of Clinical Oncology · 2026 · Same journal
• Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update · Journal of Clinical Oncology · 2026 · Same journal